US-based biopharmaceutical company Immunomedics has announced the issuance of a US patent to its majority-owned subsidiary, IBC Pharmaceuticals, for ‘Novel Strategies for Improved Cancer Vaccines’. The new patent concerns ...
Immunomedics has developed two new classes of bispecific antibodies, DOCK-AND-LOCK (DNL) complexes using its patented platform technology that enables site-specific conjugation of two self-assembling modules. The bispecific antibodies ...
Sweden based Karolinska Institutet and Immunomedics scientists have collaborated to design and test new class of drugs that destroy the AIDS virus, HIV (Human Immunodeficiency Virus), which may also help in eliminating the virus completely. ...
Tags: Immunomedics, anti-HIV agents, virus